Identification of pathogens for differential diagnosis of fever with jaundice in the Central African Republic: a retrospective assessment, 2008-2010

• Published in: BMC infectious diseases Vol. 17; no. 1; p. 735
• Main Authors: Gadia, Christelle Luce Bobossi, Manirakiza, Alexandre, Tekpa, Gaspard, Konamna, Xavier, Vickos, Ulrich, Nakoune, Emmanuel
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 29-11-2017; BioMed Central; BMC
• Subjects: Adolescent; Adult; Arbovirus Infections - diagnosis; Bacteria; Bilirubin; Central African Republic; Chikungunya Fever - diagnosis; Coinfection - epidemiology; Dengue - diagnosis; Diagnosis, Differential; Differential diagnosis; Febrile jaundice; Female; Fever - diagnosis; Fever - etiology; Health aspects; Hemorrhagic fever; Hemorrhagic Fever, Crimean - diagnosis; Hepatitis - diagnosis; Hepatitis - virology; Hepatitis C; Humans; Jaundice; Jaundice - diagnosis; Jaundice - etiology; Malaria; Malaria - diagnosis; Male; Pathogenic microorganisms; Plasmodium falciparum; Retrospective Studies; Zika Virus Infection - diagnosis; Febrile jaundice; Differential diagnosis; Central African Republic
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-017-2840-8

Febrile jaundice results clinically in generalized yellow coloration of the teguments and mucous membranes due to excess plasma bilirubin, accompanied by fever. Two types are found: conjugated and unconjugated bilirubin jaundice. Jaundice is a sign in several diseases due to viruses (viral hepatitis and arbovirus), parasites (malaria) and bacteria (leptospirosis). In the Central African Republic (CAR), only yellow fever is included on the list of diseases for surveillance. The aim of this study was to identify the other pathogens that can cause febrile jaundice, for better management of patients.
Between 2008 and 2010, 198 sera negative for yellow fever IgM were randomly selected from 2177 samples collected during yellow fever surveillance. Laboratory analyses targeted four groups of pathogens: hepatitis B, C, delta and E viruses; dengue, chikungunya, Zika, Crimean-Congo haemorrhagic fever, West Nile and Rift Valley arboviruses; malaria parasites; and bacteria (leptospirosis).
Overall, 30.9% sera were positive for hepatitis B, 20.2% for hepatitis E, 12.3% for hepatitis C and 8.2% for malaria. The majority of positive sera (40.4%) were from people aged 16-30 years. Co-infection with at least two of these pathogens was also found.
These findings suggest that a systematic investigation should be undertaken of infectious agents that cause febrile jaundice in the CAR.